Search Results for: SRC

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of ABL in ROBO-SLIT signaling
  • Role of ABL in ROBO-SLIT signaling
  • Myogenesis
  • Myogenesis
  • RHO GTPases Activate WASPs and WAVEs
  • HDR through Single Strand Annealing (SSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Cyclin D associated events in G1
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX2 regulates osteoblast differentiation
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • ATP
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • XL228
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • Myristic acid
  • PD-166326
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
  • Fostamatinib
  • Brigatinib
  • Radotinib
  • Asciminib
  • Umbralisib
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
  • Chronic myeloid leukemia (CML)
Novel ACTN1 actinin alpha 1
  • Platelet degranulation
  • Syndecan interactions
  • Nephrin family interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
  • RHOD GTPase cycle
  • RHOBTB2 GTPase cycle
  • RHOF GTPase cycle
  • Human calcitonin
  • Copper
Novel ADAM12 ADAM metallopeptidase domain 12
  • Signaling by EGFR
  • Invadopodia formation
Novel ADAM15 ADAM metallopeptidase domain 15
  • Degradation of the extracellular matrix
  • Invadopodia formation
Novel ADRB2 adrenoceptor beta 2
  • Adrenoceptors
  • G alpha (s) signalling events
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Spermine
  • Amphetamine
  • Betaxolol
  • Bethanidine
  • Isoetharine
  • Cabergoline
  • Metoprolol
  • Metoprolol
  • Olanzapine
  • Atenolol
  • Norepinephrine
  • Timolol
  • Phenylpropanolamine
  • Dipivefrin
  • Sotalol
  • Carteolol
  • Nortriptyline
  • Propranolol
  • Labetalol
  • Bisoprolol
  • Epinephrine
  • Paroxetine
  • Trimipramine
  • Cryptenamine
  • Orciprenaline
  • Dobutamine
  • Pseudoephedrine
  • Alprenolol
  • Ritodrine
  • Ritodrine
  • Terbutaline
  • Bitolterol
  • Phenoxybenzamine
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Ergoloid mesylate
  • Isoprenaline
  • Arbutamine
  • Amiodarone
  • Carvedilol
  • Desipramine
  • Propafenone
  • Acebutolol
  • Nadolol
  • Levobunolol
  • Metipranolol
  • Aripiprazole
  • Arformoterol
  • Fenoterol
  • Pirbuterol
  • Bevantolol
  • Penbutolol
  • Ephedra sinica root
  • Ephedrine
  • Mephentermine
  • Procaterol
  • Clenbuterol
  • Bambuterol
  • Oxprenolol
  • Putrescine
  • Spermidine
  • Celiprolol
  • Nebivolol
  • Indacaterol
  • Bedoradrine
  • NCX 950
  • Asenapine
  • Droxidopa
  • Bufuralol
  • Protokylol
  • (S)-carazolol
  • Bopindolol
  • Bupranolol
  • Befunolol
  • Olodaterol
  • Vilanterol
  • Viloxazine
  • Arotinolol
  • Doxofylline
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • Etafedrine
  • Tulobuterol
  • Levosalbutamol
  • Dihydroergocristine
  • Methoxyphenamine
  • Asthma
Novel ADRB3 adrenoceptor beta 3
  • Adrenoceptors
  • G alpha (s) signalling events
  • Amphetamine
  • Bethanidine
  • Metoprolol
  • Dihydroergotamine
  • Olanzapine
  • Norepinephrine
  • Nortriptyline
  • Propranolol
  • Paroxetine
  • Trimipramine
  • Cryptenamine
  • Alprenolol
  • Ritodrine
  • Terbutaline
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Ergoloid mesylate
  • Isoprenaline
  • Arbutamine
  • Amiodarone
  • Fenoterol
  • Ephedra sinica root
  • Mephentermine
  • Clenbuterol
  • Oxprenolol
  • Celiprolol
  • Nebivolol
  • Amibegron
  • Solabegron
  • Droxidopa
  • Bufuralol
  • Bopindolol
  • Bupranolol
  • Mirabegron
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • Dihydroergocristine
  • Vibegron
Novel AFAP1 actin filament associated protein 1
Novel AFAP1L2 actin filament associated protein 1 like 2
Novel AGAP1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
Novel AHR aryl hydrocarbon receptor
  • PPARA activates gene expression
  • Phase I - Functionalization of compounds
  • Endogenous sterols
  • Xenobiotics
  • Aryl hydrocarbon receptor signalling
  • Omeprazole
  • Mexiletine
  • Nimodipine
  • Flutamide
  • Atorvastatin
  • Leflunomide
  • Ginseng
  • Indirubin-3'-monoxime
  • Resveratrol
  • Quercetin
  • Tapinarof
  • beta-Naphthoflavone
  • Emodin
  • 1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine
  • Diosmin
  • Kynurenic Acid
  • Epigallocatechin gallate
  • Cantharidin
  • Indirubin
  • Carbendazim
  • Indigo
Novel AKT1 AKT serine/threonine kinase 1
  • Activation of BAD and translocation to mitochondria
  • PIP3 activates AKT signaling
  • PIP3 activates AKT signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • MTOR signalling
  • AKT phosphorylates targets in the cytosol
  • AKT phosphorylates targets in the cytosol
  • AKT phosphorylates targets in the nucleus
  • Negative regulation of the PI3K/AKT network
  • eNOS activation
  • AKT-mediated inactivation of FOXO1A
  • Integrin signaling
  • Deactivation of the beta-catenin transactivating complex
  • CD28 dependent PI3K/Akt signaling
  • Co-inhibition by CTLA4
  • G beta:gamma signalling through PI3Kgamma
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • KSRP (KHSRP) binds and destabilizes mRNA
  • VEGFR2 mediated vascular permeability
  • TP53 Regulates Metabolic Genes
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Interleukin-4 and Interleukin-13 signaling
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Cyclin E associated events during G1/S transition
  • Cyclin A:Cdk2-associated events at S phase entry
  • PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
  • RAB GEFs exchange GTP for GDP on RABs
  • RUNX2 regulates genes involved in cell migration
  • Regulation of PTEN stability and activity
  • Extra-nuclear estrogen signaling
  • Negative regulation of NOTCH4 signaling
  • FLT3 Signaling
  • Regulation of localization of FOXO transcription factors
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • KEAP1-NFE2L2 pathway
  • SARS-CoV-2 targets host intracellular signalling and regulatory pathways
  • Mitochondrial unfolded protein response (UPRmt)
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
  • Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
  • ATP
  • Arsenic trioxide
  • Genistein
  • Inositol 1,3,4,5-Tetrakisphosphate
  • Resveratrol
  • Archexin
  • Enzastaurin
  • Perifosine
  • N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
  • PTEN hamartoma tumor syndrome (PHTS), including: Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; Proteus syndrome; Proteus-like syndrome
Novel ALDOB aldolase, fructose-bisphosphate B
  • Hereditary fructose intolerance
  • Glycolysis
  • Gluconeogenesis
  • Fructose catabolism
  • 1,6-Fructose Diphosphate (Linear Form)
  • sn-glycerol 3-phosphate
  • Dihydroxyacetone phosphate
  • Hereditary fructose intolerance; Fructosemia
Novel ANKRD11 ankyrin repeat domain containing 11
Novel ANXA1 annexin A1
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Smooth Muscle Contraction
  • Interleukin-4 and Interleukin-13 signaling
  • Developmental Lineage of Pancreatic Ductal Cells
  • Amcinonide
  • Fluocinolone acetonide
  • Hydrocortisone
  • Methylprednisolone
  • Clobetasol propionate
  • Budesonide
  • Dexamethasone
  • Cortisone acetate
  • Hydrocortisone aceponate
  • Hydrocortisone acetate
  • Hydrocortisone butyrate
  • Hydrocortisone cypionate
  • Hydrocortisone phosphate
  • Hydrocortisone probutate
  • Hydrocortisone valerate
  • Prednisolone phosphate
  • Dexamethasone acetate
  • Betamethasone phosphate
Novel ANXA2 annexin A2
  • Smooth Muscle Contraction
  • Neutrophil degranulation
  • Dissolution of Fibrin Clot
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Developmental Lineage of Pancreatic Ductal Cells
  • Tenecteplase
  • Fluocinolone acetonide
  • Lanoteplase
  • Artenimol
Novel ANXA7 annexin A7
Novel AR androgen receptor
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
  • Ub-specific processing proteases
  • RUNX2 regulates osteoblast differentiation
  • RUNX2 regulates osteoblast differentiation
  • Diethylstilbestrol
  • Levonorgestrel
  • Progesterone
  • Spironolactone
  • Flutamide
  • Oxandrolone
  • Fluphenazine
  • Testosterone
  • Mitotane
  • Estrone
  • Nilutamide
  • Tamoxifen
  • Norethisterone
  • Drostanolone
  • Norgestimate
  • Nandrolone phenpropionate
  • Ketoconazole
  • Acetophenazine
  • Bicalutamide
  • Fluoxymesterone
  • Drospirenone
  • Danazol
  • Testosterone propionate
  • Oxybenzone
  • 1-Testosterone
  • Boldenone
  • Calusterone
  • Periciazine
  • Prasterone
  • Flufenamic acid
  • Stanolone
  • (R)-Bicalutamide
  • Metribolone
  • (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE
  • Cyproterone acetate
  • LGD2941
  • Dimethylcurcumin
  • Oxymetholone
  • Methyltestosterone
  • Norelgestromin
  • Stanozolol
  • Tetrahydrogestrinone
  • (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
  • BMS-564929
  • S-23
  • 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile
  • (2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide
  • Andarine
  • (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
  • (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE
  • S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE
  • 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
  • 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE
  • 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile
  • LGD-2226
  • 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL
  • Triclosan
  • Nandrolone decanoate
  • Ulipristal
  • Enzalutamide
  • Eugenol
  • Dienogest
  • Norethynodrel
  • Norgestrel
  • Homosalate
  • Enzacamene
  • Luprostiol
  • Mibolerone
  • Phenothiazine
  • Gestrinone
  • Apalutamide
  • Clascoterone
  • Darolutamide
  • Esculin
  • Ligandrol
  • Testosterone cypionate
  • Testosterone enanthate
  • Testosterone undecanoate
  • Stanolone acetate
  • Segesterone acetate
  • Boldenone undecylenate
  • Echinacoside
  • Ketodarolutamide
  • Spinal and bulbar muscular atrophy (SBMA); Kennedy's disease
  • 46,XY disorders of sex development (Other), including: Persistent Mullerian duct syndrome; Hypospadias; Cryptorchidism
  • Prostate cancer
  • 46,XY disorders of sex development (Disorders in androgen synthesis or action), including: Congenital adrenal hyperplasias; Leydig cell hypoplasia; Androgen insensitivity syndrome (AIS)
Novel ARHGAP1 Rho GTPase activating protein 1
  • RHOA GTPase cycle
  • RHOB GTPase cycle
  • RHOC GTPase cycle
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOQ GTPase cycle
  • RHOG GTPase cycle
  • RHOJ GTPase cycle
  • RAC3 GTPase cycle
  • RHOF GTPase cycle
  • RND2 GTPase cycle
Novel ARHGAP17 Rho GTPase activating protein 17
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOQ GTPase cycle
  • RAC3 GTPase cycle
Novel ARHGAP32 Rho GTPase activating protein 32
  • RHOA GTPase cycle
  • RHOB GTPase cycle
  • RHOC GTPase cycle
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RHOD GTPase cycle
  • RHOQ GTPase cycle
  • RHOG GTPase cycle
  • RHOJ GTPase cycle
  • RAC3 GTPase cycle
  • RHOF GTPase cycle
  • Regulation of CDH1 posttranslational processing and trafficking to plasma membrane

Page 1 out of 32 pages